Ignite Creation Date:
2024-05-06 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 2:28 PM
Study NCT ID:
NCT05296525
Status:
TERMINATED
Last Update Posted:
2024-05-02
First Post:
2022-03-16
Brief Title:
Evaluation of Safety and Efficacy of Allo GDA-201 NK Cells in Patients With RelapsedRefractory B Cell NHL
Sponsor:
Gamida Cell ltd
Organization:
Gamida Cell ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-04-22
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-16
First Submit QC Date:
March 16 2022
Study First Post Date:
2022-03-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-01
Last Update Post Date:
2024-05-02
Last Update Post Date Type:
ACTUAL